Tekin S

References (6)

Title : Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4\/nuclear factor-kappa B pathway - Cakir_2023_Int.Immunopharmacol_114_109586
Author(s) : Cakir M , Aydin A , Tekin S
Ref : Int Immunopharmacol , 114 :109586 , 2023
Abstract : Cakir_2023_Int.Immunopharmacol_114_109586
ESTHER : Cakir_2023_Int.Immunopharmacol_114_109586
PubMedSearch : Cakir_2023_Int.Immunopharmacol_114_109586
PubMedID: 36700769

Title : Bioactivity and molecular docking studies of some nickel complexes: New analogues for the treatment of Alzheimer, glaucoma and epileptic diseases - Kisa_2020_Bioorg.Chem_101_104066
Author(s) : Kisa D , Korkmaz N , Taslimi P , Tuzun B , Tekin S , Karadag A , Sen F
Ref : Bioorg Chem , 101 :104066 , 2020
Abstract : Kisa_2020_Bioorg.Chem_101_104066
ESTHER : Kisa_2020_Bioorg.Chem_101_104066
PubMedSearch : Kisa_2020_Bioorg.Chem_101_104066
PubMedID: 32650180

Title : Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch - Sadowsky_2010_CNS.Neurosci.Ther_16_51
Author(s) : Sadowsky C , Perez JA , Bouchard RW , Goodman I , Tekin S
Ref : CNS Neurosci Ther , 16 :51 , 2010
Abstract : Sadowsky_2010_CNS.Neurosci.Ther_16_51
ESTHER : Sadowsky_2010_CNS.Neurosci.Ther_16_51
PubMedSearch : Sadowsky_2010_CNS.Neurosci.Ther_16_51
PubMedID: 20070789

Title : Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias - Ballard_2006_Int.J.Clin.Pract_60_639
Author(s) : Ballard C , Lane R , Barone P , Ferrara R , Tekin S
Ref : Int J Clin Pract , 60 :639 , 2006
Abstract : Ballard_2006_Int.J.Clin.Pract_60_639
ESTHER : Ballard_2006_Int.J.Clin.Pract_60_639
PubMedSearch : Ballard_2006_Int.J.Clin.Pract_60_639
PubMedID: 16805745

Title : Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study - Poewe_2006_Mov.Disord_21_456
Author(s) : Poewe W , Wolters E , Emre M , Onofrj M , Hsu C , Tekin S , Lane R
Ref : Movement Disordersord , 21 :456 , 2006
Abstract : Poewe_2006_Mov.Disord_21_456
ESTHER : Poewe_2006_Mov.Disord_21_456
PubMedSearch : Poewe_2006_Mov.Disord_21_456
PubMedID: 16229010

Title : Rivastigmine for dementia associated with Parkinson's disease - Emre_2004_N.Engl.J.Med_351_2509
Author(s) : Emre M , Aarsland D , Albanese A , Byrne EJ , Deuschl G , De Deyn PP , Durif F , Kulisevsky J , van Laar T , Lees A , Poewe W , Robillard A , Rosa MM , Wolters E , Quarg P , Tekin S , Lane R
Ref : N Engl J Med , 351 :2509 , 2004
Abstract : Emre_2004_N.Engl.J.Med_351_2509
ESTHER : Emre_2004_N.Engl.J.Med_351_2509
PubMedSearch : Emre_2004_N.Engl.J.Med_351_2509
PubMedID: 15590953